Similar articles for PMID: 25750345

Year	Number of Results
1999	2
2001	3
2003	5
2004	4
2005	7
2006	14
2007	7
2008	10
2009	6
2010	6
2011	6
2012	12
2013	7
2014	7
2015	7
2016	2
2017	4
2018	4
2019	1
2020	1
2021	2
2024	0

1

Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases.

Luedders DW, Steinhoff J, Thill M, Rody A, Bohlmann MK. Luedders DW, et al. Anticancer Res. 2015 Mar;35(3):1797-802. Anticancer Res. 2015. PMID: 25750345 Clinical Trial.

2

Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.

Body JJ, Lichinitser M, Tjulandin S, Garnero P, Bergström B. Body JJ, et al. Ann Oncol. 2007 Jul;18(7):1165-71. doi: 10.1093/annonc/mdm119. Epub 2007 Apr 17. Ann Oncol. 2007. PMID: 17442659 Free article. Clinical Trial.

3

Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.

Barrett-Lee P, Casbard A, Abraham J, Hood K, Coleman R, Simmonds P, Timmins H, Wheatley D, Grieve R, Griffiths G, Murray N. Barrett-Lee P, et al. Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4. Epub 2013 Dec 11. Lancet Oncol. 2014. PMID: 24332514 Clinical Trial.

4

Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.

De Cock E, Hutton J, Canney P, Body JJ, Barrett-Lee P, Neary MP, Lewis G. De Cock E, et al. Clin Ther. 2005 Aug;27(8):1295-310. doi: 10.1016/j.clinthera.2005.08.006. Clin Ther. 2005. PMID: 16199254

5

Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.

Guay DR. Guay DR. Pharmacotherapy. 2006 May;26(5):655-73. doi: 10.1592/phco.26.5.655. Pharmacotherapy. 2006. PMID: 16637795 Review.

6

Ibandronate: its role in metastatic breast cancer.

Cameron D, Fallon M, Diel I. Cameron D, et al. Oncologist. 2006;11 Suppl 1:27-33. doi: 10.1634/theoncologist.11-90001-27. Oncologist. 2006. PMID: 16971737 Free article. Review.

7

Zoledronic acid treatment at home: safety data from an observational prospective trial.

Tassinari D, Poggi B, Nicoletti S, Fantini M, Tamburini E, Possenti C, Sartori S. Tassinari D, et al. J Palliat Med. 2007 Apr;10(2):352-8. doi: 10.1089/jpm.2006.0122. J Palliat Med. 2007. PMID: 17472506 Clinical Trial.

8

Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.

Clemons MJ, Dranitsaris G, Ooi WS, Yogendran G, Sukovic T, Wong BY, Verma S, Pritchard KI, Trudeau M, Cole DE. Clemons MJ, et al. J Clin Oncol. 2006 Oct 20;24(30):4895-900. doi: 10.1200/JCO.2006.05.9212. Epub 2006 Sep 25. J Clin Oncol. 2006. PMID: 17001071 Clinical Trial.

9

Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.

Doggrell SA. Doggrell SA. Expert Rev Anticancer Ther. 2009 Sep;9(9):1211-8. doi: 10.1586/era.09.95. Expert Rev Anticancer Ther. 2009. PMID: 19761424 Free article. Review.

10

Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y. Rosen LS, et al. Cancer J. 2001 Sep-Oct;7(5):377-87. Cancer J. 2001. PMID: 11693896 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year